Matthew Dallas
2017
In 2017, Matthew Dallas earned a total compensation of $1M as Chief Financial Officer at AVEO Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $103,564 |
|---|---|
| Option Awards | $773,750 |
| Salary | $155,017 |
| Other | $413 |
| Total | $1,032,744 |
Dallas received $773.8K in option awards, accounting for 75% of the total pay in 2017.
Dallas also received $103.6K in non-equity incentive plan, $155K in salary and $413 in other compensation.
Rankings
In 2017, Matthew Dallas' compensation ranked 8,834th out of 14,666 executives tracked by ExecPay. In other words, Dallas earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,834 out of 14,666 | 40th |
Division Manufacturing | 3,373 out of 5,772 | 42nd |
Major group Chemicals And Allied Products | 1,145 out of 2,075 | 45th |
Industry group Drugs | 911 out of 1,731 | 47th |
Industry Pharmaceutical Preparations | 715 out of 1,333 | 46th |
Source: SEC filing on April 30, 2019.
Dallas' colleagues
We found three more compensation records of executives who worked with Matthew Dallas at AVEO Pharmaceuticals in 2017.